GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biomerica BMRA · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.55

-3.73%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Biomerica

From its filings with the US Securities and Exchange Commission

SEC filings

Biomerica is based in Irvine, California and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker BMRA. The SEC classifies its business as in vitro & in vivo diagnostic substances. In the fiscal year to 31 May 2026, it reported revenue of $4.5m and a net loss of $3.8m. At that date it held total assets of $6.8m and shareholders' equity of $2.6m.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
17 Mar 1980
Employees
54
Head office
17571 VON KARMAN AVENUE, IRVINE, CA, 92614
Incorporated in
DE
Classification
In Vitro & In Vivo Diagnostic Substances
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Mr. Zackary IraniChief Executive Officer, Director, since 1994$360,103
  • Mr. Allen BarbieriExecutive Vice Chairperson of the Board and Corporate Secretary, since 1999$243,983
  • Mr. Gary LuChief Financial Officer$385,636
  • Mr. Scott MadelChief Commercial Officer
  • Mr. Eric ChinIndependent Director
  • Dr. Jane EmersonIndependent Director$137,710
  • Mr. David MoatazediIndependent Director$157,822

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Biomerica's InFoods IBS product targets IBS patients with personalized dietary solutions.
  • Biomerica serves clinical laboratories and point-of-care markets with diagnostic test kits.
  • Biomerica employs 54 full-time employees in the Health Care sector.

Weaknesses

  • Biomerica's headquarters in Irvine, California limits its geographic reach.
  • Biomerica has only 54 employees, which may hinder scalability.
  • Biomerica's business is limited to medical diagnostic products in Health Care.

Opportunities

  • Biomerica can expand its InFoods IBS product into new markets for IBS treatment.
  • Biomerica can leverage point-of-care market growth in diagnostic testing.
  • Biomerica can target chronic disease monitoring with new diagnostic products.

Threats

  • Biomerica faces competition from larger diagnostic companies in the Health Care sector.
  • Biomerica's small employee count may lead to operational challenges.
  • Biomerica's reliance on medical diagnostic products exposes it to regulatory changes.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.